|
Consolidated Statements of Operations (Unaudited) (USD $)
|
3 Months Ended | 6 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2012
|
Jun. 30, 2011
|
Dec. 31, 2011
|
Dec. 31, 2010
|
|
| Income Statement [Abstract] | ||||||
| Sales | $ 4,912,144 | $ 2,570,936 | $ 8,422,186 | $ 5,007,315 | $ 12,605,146 | $ 15,253,685 |
| Cost of sales | (2,881,472) | (1,687,705) | (4,946,353) | (3,364,764) | (8,639,658) | (8,427,608) |
| Gross profit | 2,030,672 | 883,231 | 3,475,833 | 1,642,551 | 3,965,488 | 6,826,077 |
| Operating Expenses: | ||||||
| General and administrative expenses | 1,318,504 | 1,142,497 | 2,911,873 | 2,131,662 | 7,452,864 | 6,617,249 |
| Selling expenses | 242,976 | 147,058 | 464,537 | 285,147 | ||
| Research and development expenses | 206,504 | 53,392 | 428,118 | 115,156 | 399,624 | 240,873 |
| Total Operating Expenses | 1,767,984 | 1,342,947 | 3,804,528 | 2,531,965 | 7,852,488 | 6,858,122 |
| Income (Loss) from operations | 262,688 | (459,716) | (328,695) | (889,414) | (3,887,000) | (32,045) |
| Interest expense | (1,014,852) | (108,686) | (4,487,697) | (222,195) | (1,242,853) | (439,018) |
| Gain on change in fair market value of derivative liability | 37,726 | 455,918 | (281,508) | |||
| Equity in earnings (loss) unconsolidated subsidiary | (42,677) | 55,305 | ||||
| Loss before provision for income taxes | (714,438) | (568,402) | (4,360,474) | (1,111,609) | (5,454,038) | (415,758) |
| Provision for income taxes | 3,272 | (95,945) | ||||
| Net loss | $ (714,438) | $ (568,402) | $ (4,360,474) | $ (1,111,609) | $ (5,457,310) | $ (319,813) |
| Net loss per common share | $ (0.03) | $ (0.01) | $ (0.19) | $ (0.03) | $ (0.11) | $ (0.01) |
| Basic and diluted weighted average common shares outstanding | 59,104,151 | 41,388,416 | 57,735,240 | 39,543,208 | 50,443,025 | 44,749,999 |
| X | ||||||||||
|
- Definition
Total costs related to goods produced and sold during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Net Increase or Decrease in the fair value of the derivative or group of derivatives included in earnings. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cost of borrowed funds accounted for as interest that was charged against earnings during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate revenue during the period from sale of goods in the normal course of business, before deducting returns, allowances and discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
|
- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|